Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 16, 2017 - Issue 11
Submit an article Journal homepage
2,197
Views
91
CrossRef citations to date
0
Altmetric
Review

Autoimmune diseases induced by biological agents. A review of 12,731 cases (BIOGEAS Registry)

Marta Pérez-De-LisServicio de Anestesiologia y Reanimación, Complejo Hospitalario Universitario de A Coruña, A Coruña, SpainView further author information
,
Soledad RetamozoLaboratory of Autoimmune Diseases Josep Font, IDIBAPS-CELLEX, Department of Autoimmune Diseases, ICMiD, Hospital Clínic, Barcelona, Spain;Hospital Privado Universitario de Córdoba, Córdoba, Argentina;Instituto De Investigaciones En Ciencias De La Salud (INICSA), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Córdoba, ArgentinaView further author information
,
Alejandra Flores-ChávezLaboratory of Autoimmune Diseases Josep Font, IDIBAPS-CELLEX, Department of Autoimmune Diseases, ICMiD, Hospital Clínic, Barcelona, Spain;Unidad de Investigación Biomédica 02, Unidad de Investigación en Epidemiología Clínica, Centro Médico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), Hospital de Especialidades, Guadalajara, Mexico;Programa de Doctorado en Ciencias Médicas, Centro Universitario de Investigaciones Biomédicas (CUIB), Universidad de Colima, Colima, MexicoView further author information
,
Belchin KostovPrimary Care Research Group, IDIBAPS, Barcelona, SpainView further author information
,
Roberto Perez-AlvarezDepartment of Internal Medicine, Hospital Alvaro Cunqueiro, Vigo, SpainView further author information
,
Pilar Brito-ZerónLaboratory of Autoimmune Diseases Josep Font, IDIBAPS-CELLEX, Department of Autoimmune Diseases, ICMiD, Hospital Clínic, Barcelona, Spain;Autoimmune Diseases Unit, Department of Medicine, Hospital CIMA- Sanitas, Barcelona, SpainView further author information
&
Manuel Ramos-CasalsLaboratory of Autoimmune Diseases Josep Font, IDIBAPS-CELLEX, Department of Autoimmune Diseases, ICMiD, Hospital Clínic, Barcelona, Spain;Department of Medicine, University of Barcelona, Barcelona, SpainCorrespondence[email protected]
View further author information
 show all
Pages 1255-1271 | Received 06 Jul 2017, Accepted 24 Aug 2017, Published online: 07 Sep 2017

Citations (91)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Ogugua Ndili Obi, Elyse E. Lower & Robert P. Baughman. (2021) Biologic and advanced immunomodulating therapeutic options for sarcoidosis: a clinical update. Expert Review of Clinical Pharmacology 14:2, pages 179-210.
Read now
Vassiliki Tzanetakou, Dimitra Stergianou & Evangelos J. Giamarellos-Bourboulis. (2020) Long-term safety of adalimumab for patients with moderate-to-severe hidradenitis suppurativa. Expert Opinion on Drug Safety 19:4, pages 381-393.
Read now
Tanya Kowalski & Heather G Mack. (2020) Ocular complications of tumour necrosis factor alpha inhibitors. Clinical and Experimental Optometry 103:2, pages 148-154.
Read now
Fabio Salvatore Macaluso, Chiara Sapienza, Marco Ventimiglia, Sara Renna, Mario Cottone & Ambrogio Orlando. (2019) Lupus-like reactions in patients with inflammatory bowel disease treated with anti-TNFs are insidious adverse events: data from a large single-center cohort. Scandinavian Journal of Gastroenterology 54:9, pages 1102-1106.
Read now
Narges E Omran & Abdulsalam A Noorwali. (2018) Nephritis, cerebritis, and myositis after adalimumab therapy in a patient with rheumatoid arthritis: a case report. International Journal of General Medicine 11, pages 151-154.
Read now

Articles from other publishers (86)

Ioana Ruxandra Mihai, Alexandra Maria Burlui, Ioana Irina Rezus, Cătălina Mihai, Luana Andreea Macovei, Anca Cardoneanu, Otilia Gavrilescu, Mihaela Dranga & Elena Rezus. (2023) Inflammatory Bowel Disease as a Paradoxical Reaction to Anti-TNF-α Treatment—A Review. Life 13:8, pages 1779.
Crossref
Ludovico De Stefano, Francesca Bobbio Pallavicini, Eleonora Mauric, Veronica Piccin, Enrico Maria Vismara, Carlomaurizio Montecucco & Serena Bugatti. (2023) Tumor necrosis factor-α inhibitor-related autoimmune disorders. Autoimmunity Reviews 22:7, pages 103332.
Crossref
Loris Riccardo Lopetuso, Claudia Cuomo, Irene Mignini, Antonio Gasbarrini & Alfredo Papa. (2023) Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases. International Journal of Molecular Sciences 24:9, pages 8187.
Crossref
Ming-Li Chen, Tanawin Nopsopon & Ayobami Akenroye. (2023) Incidence of Anti-Drug Antibodies to Monoclonal Antibodies in Asthma: A Systematic Review and Meta-Analysis. The Journal of Allergy and Clinical Immunology: In Practice 11:5, pages 1475-1484.e20.
Crossref
Tommy Harty, Michelle O’Shaughnessy & Sinead Harney. (2023) Therapeutics in rheumatology and the kidney. Rheumatology 62:3, pages 1009-1020.
Crossref
Frederick W Miller. (2023) The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention. Current Opinion in Immunology 80, pages 102266.
Crossref
Tumay Ak, Rana Berru Durmus & Muhammed Onel. (2022) Cutaneous vasculitis associated with molecular tergeted therapies: systematic review of the literature. Clinical Rheumatology 42:2, pages 339-357.
Crossref
Iuliana Iordan, Dan-Corneliu Jinga, Claudiu Dragoş Popescu & Ana Maria Vlădăreanu. (2023) Complicaţii mediate imunologic ale anticorpilor monoclonali folosiţi în oncohematologie. Oncolog-Hematolog.ro 1:62, pages 26.
Crossref
Anna Way & Elena Weinstein. (2023) A Rare Case of Infliximab-Induced Small Vessel Vasculitis With Renal Involvement. Journal of Investigative Medicine High Impact Case Reports 11.
Crossref
John M. Bridges & Walter Winn Chatham. 2023. Clinical Immunology. Clinical Immunology 1089 1101 .
Yoshinori Kawabata. 2023. Tuberculosis. Tuberculosis 1003 1031 .
Huizhu Guo, Peitao Zhang, Ruiqiu Zhang, Yuqing Hua, Pei Zhang, Xueyan Cui, Xin Huang & Xiao Li. (2022) Modeling and insights into the structural characteristics of drug-induced autoimmune diseases. Frontiers in Immunology 13.
Crossref
David Gritsch & Cristina Valencia-Sanchez. (2022) Drug-related immune-mediated myelopathies. Frontiers in Neurology 13.
Crossref
Manuel Ramos-Casals, Alejandra Flores-Chávez, Pilar Brito-Zerón, Olivier Lambotte & Xavier Mariette. (2022) Immune-related adverse events of cancer immunotherapies targeting kinases. Pharmacology & Therapeutics 237, pages 108250.
Crossref
Fumi Miyagawa. (2022) Pathogenesis of Paradoxical Reactions Associated with Targeted Biologic Agents for Inflammatory Skin Diseases. Biomedicines 10:7, pages 1485.
Crossref
Camila da Silva Cendon Duran, Adriane Souza da Paz & Mittermayer Barreto Santiago. (2022) Vasculitis induced by biological agents used in rheumatology practice: A systematic review. Archives of Rheumatology 37:2, pages 300-310.
Crossref
Kendall S. Frazier. (2022) Kidney Effects by Alternative Classes of Medicines in Patients and Relationship to Effects in Nonclinical Toxicity Studies. Toxicologic Pathology 50:4, pages 408-414.
Crossref
Michael J. Murphy, Jeffrey M. Cohen, Matthew D. Vesely & William Damsky. (2022) Paradoxical eruptions to targeted therapies in dermatology: A systematic review and analysis. Journal of the American Academy of Dermatology 86:5, pages 1080-1091.
Crossref
Sophie M. Poznanski, Ana Portillo, Manali Mukherjee, Anurag Bhalla, Kiho Son, Ali A. Ashkar, Nader Khalidi & Parameswaran Nair. (2022) Benralizumab's anti-eosinophil efficacy may be decreased by impaired NK cell activity. European Respiratory Journal 59:4, pages 2102210.
Crossref
Tam D. Quach, Weiqing Huang, Ranjit Sahu, Catherine M.M. Diadhiou, Chirag Raparia, Roshawn Johnson, Tung Ming Leung, Susan Malkiel, Peta Gay Ricketts, Stefania Gallucci, Çagla Tükel, Chaim O. Jacob, Martin L. Lesser, Yong-Rui Zou & Anne Davidson. (2022) Context-dependent induction of autoimmunity by TNF signaling deficiency. JCI Insight 7:5.
Crossref
Igor Kremenevski, Oliver Sander, Michael Sticherling & Martin Raithel. (2022) Paradoxical reactions to biologicals in chronic inflammatory systemic diseases. Deutsches Ärzteblatt international.
Crossref
Thalita Basso Scandolara, Leticia Madureira Pacholak, Isabella Morais Tavares, Rodrigo Kern, Leonardo Garcia-Velazquez & Carolina Panis. 2022. Translational Autoimmunity. Translational Autoimmunity 15 49 .
Nima Rezaei & Niloufar Yazdanpanah. 2022. Translational Autoimmunity. Translational Autoimmunity 1 13 .
Negar Molazadeh, Sara Ala, Maryam Karaminia & Mohammad Ali Sahraian. (2021) Rituximab induced psoriasis in a patient with multiple sclerosis: A case report and literature review. Neuroimmunology Reports 1, pages 100027.
Crossref
Carolina M Rimkus, Vinicius Andreoli Schoeps, Mateus Boaventura, Luis Filipe Godoy, Samira Luisa Apostolos-Pereira, Ana Luisa Calich, Dagoberto Callegaro, Leandro Tavares Lucato, Alex Rovira, Jaume Sastre-Garriga & Claudia da Costa Leite. (2021) Drug-related demyelinating syndromes: understanding risk factors, pathophysiological mechanisms and magnetic resonance imaging findings. Multiple Sclerosis and Related Disorders 55, pages 103146.
Crossref
A. N. Kovshik, E. P. Kiseleva, N. G. Klyukvina & G. V. Lukina. (2021) Development of sulfasalazine-associated drug-induced lupus erythematosus in patient with rheumatoid arthritis (clinical case). Medical alphabet:16, pages 26-29.
Crossref
Jamie L. Waldron, Stephen A. Schworer & Mildred Kwan. (2021) Hypersensitivity and Immune-related Adverse Events in Biologic Therapy. Clinical Reviews in Allergy & Immunology 62:3, pages 413-431.
Crossref
Spencer K. Hutto, Dylan R. Rice & Farrah J. Mateen. (2021) CNS demyelination with TNFα inhibitor exposure: A retrospective cohort study. Journal of Neuroimmunology 356, pages 577587.
Crossref
Mrudula Thiriveedi, Taylor D. Steuber, Mohamed Hasan & Alan Baggett. (2021) Infliximab-Induced Lupus Causing Pericarditis: a Case Report and Review of the Literature. Journal of General Internal Medicine 36:7, pages 2134-2138.
Crossref
Manuel Ramos-Casals, Pilar Brito-Zerón & Xavier Mariette. (2021) Systemic and organ-specific immune-related manifestations of COVID-19. Nature Reviews Rheumatology 17:6, pages 315-332.
Crossref
Jagannadha Avasarala, Zain Guduru, Christopher J. McLouth, Amanda Wilburn, Jeffrey Talbert, Paige Sutton & Brent S. Sokola. (2021) Use of anti-TNF-α therapy in Crohn's disease is associated with increased incidence of multiple sclerosis. Multiple Sclerosis and Related Disorders 51, pages 102942.
Crossref
S. H. Verspohl, H. Schulze-Koops, A. Heine & V. S. Schäfer. (2021) Prävalenz und Therapie von rheumatologischen Nebenwirkungen bei Immun-Checkpoint-Inhibitor-TherapiePrevalence and treatment of rheumatological adverse events due to immune checkpoint inhibitor therapy. rheuma plus 20:3, pages 116-126.
Crossref
Thomas R.P. TaylorJames GallowayRebecca DaviesKimme HyrichRuth Dobson. (2021) Demyelinating Events Following Initiation of Anti-TNFα Therapy in the British Society for Rheumatology Biologics Registry in Rheumatoid Arthritis. Neurology Neuroimmunology & Neuroinflammation 8:3.
Crossref
Sam Talbot, Vivienne MacLaren & Heather Lafferty. (2021) Sclerosing cholangitis in a patient treated with nivolumab. BMJ Case Reports 14:5, pages e241700.
Crossref
Matteo Lucchini, Guido Maria Giuffrè, Viviana Nociti, Assunta Bianco, Chiara De Fino, Francesco Antonio Losavio, Giorgia Presicce, Paolo Calabresi & Massimiliano Mirabella. (2021) Defining the disease course of TNFα blockers-associated Multiple Sclerosis. Journal of Neuroimmunology 353, pages 577525.
Crossref
Xin Su, Ye Cheng & Dong Chang. (2021) Lipid-lowering therapy: Guidelines to precision medicine. Clinica Chimica Acta 514, pages 66-73.
Crossref
Elisabetta Chessa, Matteo Piga, Alberto Floris, Mattia Congia, Ignazio Cangemi, Alessandro Mathieu & Alberto Cauli. (2021) Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review. BioDrugs 35:2, pages 175-186.
Crossref
Ilaria Mormile, Francescopaolo Granata, Alessandra Punziano, Amato de Paulis & Francesca Wanda Rossi. (2021) Immunosuppressive Treatment in Antiphospholipid Syndrome: Is It Worth It?. Biomedicines 9:2, pages 132.
Crossref
K. Michael PollardDavid M. Cauvi, Jessica M. MayeuxChristopher B. Toomey, Amy K. PeissPer Hultman & Dwight H. Kono. (2021) Mechanisms of Environment-Induced Autoimmunity. Annual Review of Pharmacology and Toxicology 61:1, pages 135-157.
Crossref
Sophia H. Verspohl, Tobias Holderried, Charlotte Behning, Peter Brossart & Valentin S. Schäfer. (2021) Prevalence, therapy and tumour response in patients with rheumatic immune-related adverse events following immune checkpoint inhibitor therapy: a single-centre analysis. Therapeutic Advances in Musculoskeletal Disease 13, pages 1759720X2110069.
Crossref
Simon Hirschmann, Sarah Fischer, Entcho Klenske, Katharina Dechant, Jörg H.W. Distler, Christoph Treutlein, Markus F. Neurath & Raja Atreya. (2021) Case report of severe constrictive perimyocarditis and ischemic hepatitis in a Crohn’s disease patient upon infliximab-induced lupus-like syndrome. Therapeutic Advances in Gastroenterology 14, pages 175628482110440.
Crossref
Meiqi Yang, Weixin Liu, Qiuping Deng, Zeng Liang & Qin Wang. (2021) The incidence of psoriasis among smokers and/or former smokers inflammatory bowel diseases patients treated with tumor necrosis factor antagonist. Medicine 100:42, pages e27510.
Crossref
Tamiko R. Katsumoto & Xavier Mariette. 2021. Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy. Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy 169 189 .
Xerxes Pundole, Manuel Ramos-Casals & Olivier Lambotte. 2021. Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy. Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy 143 167 .
Louise Gaboriau, Jean-Baptiste Davion, Sandrine Combret, Bénédicte Lebrun-Vignes, Fanny Rocher, Franck Rouby, Florence Renaud, Sandrine Morell-Dubois & Sophie Gautier. (2020) Adalimumab and myositis: A case report and review of the French and international Pharmacovigilance Databases. Neuromuscular Disorders 30:11, pages 915-920.
Crossref
B. Demarez, F. Amatore, S. Lagarde, N. Bruder, J.J. Grob & M.A. Richard. (2020) Anti‐ N ‐methyl‐ D ‐aspartate receptor encephalitis during treatment with adalimumab for psoriasis . Journal of the European Academy of Dermatology and Venereology 34:10.
Crossref
S. H. Verspohl, H. Schulze-Koops, A. Heine & V. S. Schäfer. (2020) Prävalenz und Therapie von rheumatologischen Nebenwirkungen bei Immun-Checkpoint-Inhibitor-TherapiePrevalence and treatment of rheumatological adverse events due to immune checkpoint inhibitor therapy. Zeitschrift für Rheumatologie 79:8, pages 797-808.
Crossref
Uma Thanarajasingam & Noha Abdel-Wahab. (2020) Immune Checkpoint Inhibition—Does It Cause Rheumatic Diseases? Mechanisms of Cancer-Associated Loss of Tolerance and Pathogenesis of Autoimmunity. Rheumatic Disease Clinics of North America 46:3, pages 587-603.
Crossref
Paola Triggianese, Lucia Novelli, Maria Rosaria Galdiero, Maria Sole Chimenti, Paola Conigliaro, Roberto Perricone, Carlo Perricone & Roberto Gerli. (2020) Immune checkpoint inhibitors-induced autoimmunity: The impact of gender. Autoimmunity Reviews 19:8, pages 102590.
Crossref
Amy Kunchok, Allen J. AksamitJrJr, John M. DavisIIIIII, Orhun H. Kantarci, B. Mark Keegan, Sean J. Pittock, Brian G. Weinshenker & Andrew McKeon. (2020) Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System Events. JAMA Neurology 77:8, pages 937.
Crossref
Andrea Pagan, Yadis M Arroyo-Martinez, Ankita Tandon, Carlos Bertran-Rodriguez & Jeffrey Gill. (2020) Immune Checkpoint Inhibitor-Induced Acute Pancreatitis and Colitis. Cureus.
Crossref
Moshe Loebenstein & Julien D. Schulberg. (2020) Anti-TNF Rechallenge After Infliximab Induced Lupus in Crohn’s Disease. Gastroenterology 158:8, pages 2069-2071.
Crossref
Konstantinos Melissaropoulos, Kalliopi Klavdianou, Alexandra Filippopoulou, Fotini Kalofonou, Haralabos Kalofonos & Dimitrios Daoussis. (2020) Rheumatic Manifestations in Patients Treated with Immune Checkpoint Inhibitors. International Journal of Molecular Sciences 21:9, pages 3389.
Crossref
Karsten Conrad, Yehuda Shoenfeld & Marvin J. Fritzler. (2020) Precision health: A pragmatic approach to understanding and addressing key factors in autoimmune diseases. Autoimmunity Reviews 19:5, pages 102508.
Crossref
Alice Indini, Maria Sessa, Barbara Merelli, Camillo Foresti & Mario Mandalà. (2020) A case of severe pharyngeal-cervical-brachial syndrome induced by nivolumab and responding to infliximab therapy. European Journal of Cancer 129, pages 1-3.
Crossref
Robert W. Dunstan. 2020. Biomarkers in Drug Discovery and Development. Biomarkers in Drug Discovery and Development 233 253 .
Ömer Kutlu, Pınar Çetinkaya, Tijen Şahin & HaticeMeral Ekşioǧlu. (2020) The effect of biological agents on antinuclear antibody status in patients with psoriasis: A single-center study. Indian Dermatology Online Journal 11:6, pages 904.
Crossref
Marvin I. De los Santos, Denise Mirano Bacos & Samuel D. Bernal. (2020) WITHDRAWN: A novel bifunctional T regulatory cell engaging (BiTE) TGF-β1/PD-L1 fusion protein with therapeutic potential for autoimmune diseases. Journal of Translational Autoimmunity, pages 100037.
Crossref
Jan Leipe & Xavier Mariette. (2019) Management of rheumatic complications of ICI therapy: a rheumatology viewpoint. Rheumatology 58:Supplement_7, pages vii49-vii58.
Crossref
Noha Abdel-Wahab & Maria E Suarez-Almazor. (2019) Frequency and distribution of various rheumatic disorders associated with checkpoint inhibitor therapy. Rheumatology 58:Supplement_7, pages vii40-vii48.
Crossref
Theodora Bejan-Angoulvant & Joachim Alexandre. (2020) Mécanismes d’action et toxicités potentielles des anticorps monoclonaux. médecine/sciences 35:12, pages 1114-1120.
Crossref
Jeffrey R. Curtis & James D. Lewis. 2019. Pharmacoepidemiology. Pharmacoepidemiology 561 580 .
Jaume Alijotas-Reig, Enrique Esteve-Valverde, Elisa Llurba & Josep Mª Gris. (2019) Treatment of refractory poor aPL-related obstetric outcomes with TNF-alpha blockers: Maternal-fetal outcomes in a series of 18 cases. Seminars in Arthritis and Rheumatism 49:2, pages 314-318.
Crossref
Minami Uchida, Koju Kamoi, Naoko Ando, Chenxi Wei, Hisako Karube & Kyoko Ohno-Matsui. (2019) Safety of Infliximab for the Eye Under Human T-Cell Leukemia Virus Type 1 Infectious Conditions in vitro. Frontiers in Microbiology 10.
Crossref
Juan M Mejia-Vilet, Samir V Parikh, Huijuan Song, Paolo FaddaJohn P Shapiro, Isabelle Ayoub, Lianbo Yu, Jianying Zhang, Norma Uribe-Uribe & Brad H Rovin. (2019) Immune gene expression in kidney biopsies of lupus nephritis patients at diagnosis and at renal flare. Nephrology Dialysis Transplantation 34:7, pages 1197-1206.
Crossref
Joon-Il Lee, Kyoung Sun Park & Ik-Hyun Cho. (2019) Panax ginseng: a candidate herbal medicine for autoimmune disease. Journal of Ginseng Research 43:3, pages 342-348.
Crossref
Yohei Iimura, Shigeatsu Motoori, Keiko Imanaka, Tomohiko Yoshida & Minoru Takemoto. (2019) A Case of Drug-induced Insulin Autoimmune Syndrome which were Developed during the Course of Treatment for Anal Adenocarcinoma肛門腺癌治療中に発症した薬剤誘発性インスリン自己免疫症候群の1例. Nihon Naika Gakkai Zasshi 108:4, pages 784-790.
Crossref
J.-L. Schmutz. (2019) Lupus induits : les nouveautés. Annales de Dermatologie et de Vénéréologie 146:4, pages 340-342.
Crossref
Jakub Wroński & Piotr Fiedor. (2018) The Safety Profile of Tumor Necrosis Factor Inhibitors in Ankylosing Spondylitis: Are TNF Inhibitors Safer Than We Thought?. The Journal of Clinical Pharmacology 59:4, pages 445-462.
Crossref
Theodoros Karampitsakos, Argyro Vraka, Demosthenes Bouros, Stamatis-Nick Liossis & Argyris Tzouvelekis. (2019) Biologic Treatments in Interstitial Lung Diseases. Frontiers in Medicine 6.
Crossref
Yehuda Shoenfeld, Michael Ehrenfeld & Ori Perry. (2019) The kaleidoscope of autoimmunity – From genes to microbiome. Clinical Immunology 199, pages 1-4.
Crossref
Fariba Rad, Mohammad Ghorbani, Amaneh Mohammadi Roushandeh & Mehryar Habibi Roudkenar. (2019) Mesenchymal stem cell-based therapy for autoimmune diseases: emerging roles of extracellular vesicles. Molecular Biology Reports 46:1, pages 1533-1549.
Crossref
Kendall S. Frazier & Leslie A. Obert. (2018) Drug-induced Glomerulonephritis: The Spectre of Biotherapeutic and Antisense Oligonucleotide Immune Activation in the Kidney. Toxicologic Pathology 46:8, pages 904-917.
Crossref
Sena Tolu, Aylin Rezvani, Nurbanu Hindioglu & Merve Calkin Korkmaz. (2018) Etanercept-induced Crohn’s disease in ankylosing spondylitis: a case report and review of the literature. Rheumatology International 38:11, pages 2157-2162.
Crossref
A. O. Golovenko & O. V. Golovenko. (2018) Vedolizumab in the treatment of inflammatory bowel diseases: whom and how?. Medical Council:14, pages 44-49.
Crossref
Eda Derle & Sibel Benli. (2018) Ipilimumab treatment associated with myasthenic crises and unfavorable disease course. Neurological Sciences 39:10, pages 1773-1774.
Crossref
Geoffrey P. NobleEric Lancaster. (2018) Anti–NMDAR encephalitis in a patient with Crohn disease receiving adalimumab. Neurology Neuroimmunology & Neuroinflammation 5:5.
Crossref
Augusto Vaglio, Peter C. Grayson, Paride Fenaroli, Davide Gianfreda, Valeria Boccaletti, Gian Marco Ghiggeri & Gabriella Moroni. (2018) Drug-induced lupus: Traditional and new concepts. Autoimmunity Reviews 17:9, pages 912-918.
Crossref
Cecilia Beatrice Chighizola & Pier Luigi Meroni. (2018) Thrombosis and Anti-phospholipid Syndrome: a 5-Year Update on Treatment. Current Rheumatology Reports 20:7.
Crossref
Philippe Bonniaud, Guillaume Beltramo, Clément Foignot, Paul Ornetti & Marjolaine Georges. (2018) Pneumopathies non infectieuses induites par les biothérapies ciblées. Revue du Rhumatisme Monographies 85:3, pages 184-190.
Crossref
Cecilia Beatrice Chighizola, Laura Andreoli, Maria Gerosa, Angela Tincani, Amelia Ruffatti & Pier Luigi Meroni. (2018) The treatment of anti-phospholipid syndrome: A comprehensive clinical approach. Journal of Autoimmunity 90, pages 1-27.
Crossref
Sophie Steeland, Claude Libert & Roosmarijn E. Vandenbroucke. (2018) A New Venue of TNF Targeting. International Journal of Molecular Sciences 19:5, pages 1442.
Crossref
P. L. A. van Daele. (2018) Complicaties van behandeling met biologicals. Bijblijven 34:2, pages 160-166.
Crossref
Vincent P. Mauro. (2018) Codon Optimization in the Production of Recombinant Biotherapeutics: Potential Risks and Considerations. BioDrugs 32:1, pages 69-81.
Crossref
Kurt G. Tournoy, Michiel Thomeer, Paul Germonpré, Sofie Derijcke, Rebecca De Pauw, Daniëlla Galdermans, Karl Govaert, Elke Govaerts, Rob Schildermans, Isabelle Declercq, Nele De Brucker, Karin Pat, Rika Van Herreweghe, Luc Van Zandweghe, Luc Vanmaele, Valerie Van Damme, Heidi Marien, Sofie De Craene, Isabelle Fabry, Patrick Alexander, Piet Vercauter & Ingel Demedts. (2018) Does nivolumab for progressed metastatic lung cancer fulfill its promises? An efficacy and safety analysis in 20 general hospitals. Lung Cancer 115, pages 49-55.
Crossref
Z. Al-Falahi & S. Lo. (2018) Nivolumab-Induced Fatal Fulminant Myocarditis Presenting as Complete Heart Block in a Patient With Metastatic Renal Cell Carcinoma. Heart, Lung and Circulation 27, pages S114-S115.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.